Artigo
Acesso aberto
Revisado por pares
Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report
2022; Soc for Publication of Acta Dermato-Venereologica; Volume: 102; Linguagem: Inglês
10.2340/actadv.v102.1378
ISSN1651-2057
Autores Tópico(s)Coagulation, Bradykinin, Polyphosphates, and Angioedema
ResumoAbstract is missing (Short communication)
Referência(s)